Insider Transactions in Q1 2025 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Feb 21
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,202
-75.87%
|
$310,116
$258.58 P/Share
|
Feb 21
2025
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Indirect |
5,000
-42.67%
|
$1,285,000
$257.41 P/Share
|
Feb 20
2025
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
21,267
-100.0%
|
$5,104,080
$240.07 P/Share
|
Feb 20
2025
|
Xiaobin Wu President, COO & GM China |
BUY
Exercise of conversion of derivative security
|
Direct |
21,267
+50.0%
|
$3,594,123
$169.65 P/Share
|
Feb 18
2025
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
30,654
-78.45%
|
$7,387,614
$241.22 P/Share
|
Feb 18
2025
|
Xiaobin Wu President, COO & GM China |
BUY
Exercise of conversion of derivative security
|
Direct |
30,654
+50.0%
|
$5,180,526
$169.65 P/Share
|
Feb 04
2025
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
41,760
-47.05%
|
$9,396,000
$225.64 P/Share
|
Feb 04
2025
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,760
+50.0%
|
$250,560
$6.5 P/Share
|
Jan 07
2025
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
41,760
-63.13%
|
$7,391,520
$177.42 P/Share
|
Jan 07
2025
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,760
+50.0%
|
$250,560
$6.5 P/Share
|